Principal Investigator
LAWRENCE NEGRET
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231376
Clinical Trial Summary
Randomized Phase II Trial Of Lutetium Lu 177 Dotatate Versus Everolimus In Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors
Phase
Phase II
Funding Agency/Sponsor
National Cooperative Group
Disease
Thoracic Oncology
Contact Information
Phone Number
+1 (305) 2437261